Nuclear Medicine: Page 116

Prostate radiotracer may benefit breast cancer imaging
By Wayne Forrest
A radiotracer recently cleared for PET imaging of recurrent prostate cancer may have similar efficacy for certain forms of breast cancer, according to a study presented at last week's Society of Nuclear Medicine and Molecular Imaging meeting.
June 23, 2016
2016 06 21 14 49 54 755 Fluciclovine 200
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
June 21, 2016
Shine lands Chinese contract
By AuntMinnie.com staff writers
Shine Medical Technologies has won a contract to provide molybdenum-99 to Chinese radiopharmaceutical provider HTA.
June 20, 2016
Navidea touts Lymphoseek research
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attention to three studies involving its Lymphoseek radiopharmaceutical presented at last week's Society of Nuclear Medicine and Molecular Imaging meeting in San Diego.
June 19, 2016
Cell>Point signs licensing deal in China
By AuntMinnie.com staff writers
Biotechnology firm Cell>Point has inked a licensing deal with U.S. and China consortium United Eastern Pharmaceutical for its Oncardia radiopharmaceutical in China, Hong Kong, and Macau.
June 16, 2016
SNMMI: Optical-gamma imaging hybrid shows promise
By AuntMinnie.com staff writers
A work-in-progress hybrid optical-gamma imaging system can provide a visual representation of molecular data in the same frame as optical images of surface anatomy such as the skin and eyes, according to research presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in San Diego.
June 14, 2016
Sofie, PerkinElmer continue PET partnership
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences and life sciences firm PerkinElmer have inked a multiyear extension of their existing partnership to develop preclinical in vivo imaging tools for PET.
June 14, 2016
SNMMI: FDG-PET predicts breast cancer outcomes
By Wayne Forrest
SAN DIEGO - FDG-PET is a considerably better predictor of treatment response and outcome than fluoride-PET for breast cancer patients with metastatic bone lesions, concluded researchers on Tuesday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference.
June 14, 2016
2016 06 15 10 08 34 107 Peterson Snmmi Fdg 200
Novel PET combination awarded SNMMI Image of the Year
By Wayne Forrest
SAN DIEGO - German researchers have received this year's Image of the Year award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for the use of three different radiotracers with PET to measure amyloid plaques, tau tangles, and metabolic activity in the brains of living Alzheimer's patients.
June 14, 2016
2016 06 13 14 03 58 302 Snmmi Image Year 200
SNMMI coverage | Cutting dose in low-dose CT | Enterprise imaging
By Erik L. Ridley
June 13, 2016
SNMMI: FDG-PET can monitor immunotherapy for NSCLC
By AuntMinnie.com staff writers
FDG-PET can be used to monitor and predict outcomes from immunotherapy treatment of non-small cell lung cancer (NSCLC), according to research presented this week at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in San Diego.
June 13, 2016
Dilon highlights molecular breast tomo device at SNMMI
By AuntMinnie.com staff writers
Molecular breast imaging developer Dilon Diagnostics is highlighting new molecular breast tomosynthesis technology at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in San Diego.
June 13, 2016
Previous Page
Page 116 of 445
Next Page